• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-17A诱导高血压的机制及前沿应用综述

Review of mechanisms and frontier applications in IL-17A-induced hypertension.

作者信息

Li Ruiyuan, Guo Lipeng, Liang Bin, Sun Wei, Hai Feng

机构信息

Graduate School of Jinzhou Medical University, Jinzhou, Liaoning, China.

Department of Cardiology, Dalian Third People's Hospital of Jinzhou Medical University, Dalian, 116033, Liaoning, China.

出版信息

Open Med (Wars). 2025 Feb 27;20(1):20251159. doi: 10.1515/med-2025-1159. eCollection 2025.

DOI:10.1515/med-2025-1159
PMID:40028265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11868716/
Abstract

BACKGROUND

The immune system is closely related to hypertension. Hypertension is an immune disorder to a certain extent, and inflammation is the basis of abnormally elevated blood pressure (BP). The accumulation of T cells and their cytokines can increase BP and end organ damage. T cells are activated by antigen-presenting cells of the innate immune system or by the influence of a high-sodium diet, the self-environment, or the gut microbiota. These cells produce inflammatory factors and cytokines, such as interleukin-17A (IL-17A) in T helper 17 cells, causing vascular inflammation, hypertension, and target organ damage.

METHODS

In this article, we provide an insightful review of the research progress regarding the role of IL-17A in the pathogenesis of hypertension and its effects on different organs while emphasizing the role of IL-17A and its mediated functions in the kidneys, brain, intestines, and vascular system in the development and progression of hypertension.

RESULTS

At the organ level, IL-17A is involved in the development and progression of hypertension in the kidneys, brain, intestines, and blood vessels, interacting with multiple signal pathway.

CONCLUSIONS

These findings have significant implications for developing future immunomodulatory therapies, which may lead to the development of potential treatments for hypertension.

摘要

背景

免疫系统与高血压密切相关。高血压在一定程度上是一种免疫紊乱,炎症是血压异常升高的基础。T细胞及其细胞因子的积累会增加血压并导致靶器官损伤。T细胞可被先天性免疫系统的抗原呈递细胞激活,或受高钠饮食、自身环境或肠道微生物群的影响。这些细胞产生炎症因子和细胞因子,如辅助性T细胞17中的白细胞介素-17A(IL-17A),导致血管炎症、高血压和靶器官损伤。

方法

在本文中,我们对IL-17A在高血压发病机制中的作用及其对不同器官的影响的研究进展进行了深入综述,同时强调了IL-17A及其介导的功能在高血压发生和发展过程中在肾脏、大脑、肠道和血管系统中的作用。

结果

在器官水平上,IL-17A参与肾脏、大脑、肠道和血管中高血压的发生和发展,并与多种信号通路相互作用。

结论

这些发现对未来免疫调节疗法的开发具有重要意义,这可能会带来高血压潜在治疗方法的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffc/11868716/05c2f2b25cc4/j_med-2025-1159-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffc/11868716/739803a49a76/j_med-2025-1159-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffc/11868716/05c2f2b25cc4/j_med-2025-1159-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffc/11868716/739803a49a76/j_med-2025-1159-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dffc/11868716/05c2f2b25cc4/j_med-2025-1159-fig002.jpg

相似文献

1
Review of mechanisms and frontier applications in IL-17A-induced hypertension.白细胞介素-17A诱导高血压的机制及前沿应用综述
Open Med (Wars). 2025 Feb 27;20(1):20251159. doi: 10.1515/med-2025-1159. eCollection 2025.
2
Interleukin 17A: Key Player in the Pathogenesis of Hypertension and a Potential Therapeutic Target.白细胞介素 17A:高血压发病机制中的关键因子及潜在治疗靶点。
Curr Hypertens Rep. 2021 Mar 5;23(3):13. doi: 10.1007/s11906-021-01128-7.
3
Interleukin-17A: Potential mediator and therapeutic target in hypertension.白细胞介素-17A:高血压的潜在介质和治疗靶点。
Nefrologia (Engl Ed). 2021 May-Jun;41(3):244-257. doi: 10.1016/j.nefroe.2021.06.003. Epub 2021 Jul 14.
4
Interleukin-17A: Possible mediator and therapeutic target in hypertension.白细胞介素-17A:高血压的可能介质和治疗靶点。
Nefrologia (Engl Ed). 2021 May-Jun;41(3):244-257. doi: 10.1016/j.nefro.2020.11.009. Epub 2021 Mar 26.
5
Inhibition of Interleukin 17-A but not Interleukin-17F Signaling Lowers Blood Pressure and Reduces End-organ Inflammation in Angiotensin II-induced Hypertension.抑制白细胞介素17 - A而非白细胞介素17F信号通路可降低血压并减轻血管紧张素II诱导的高血压中的终末器官炎症。
JACC Basic Transl Sci. 2016 Dec;1(7):606-616. doi: 10.1016/j.jacbts.2016.07.009. Epub 2016 Nov 16.
6
Inflammation in Salt-Sensitive Hypertension and Renal Damage.盐敏感性高血压与肾脏损害中的炎症反应。
Curr Hypertens Rep. 2018 Oct 30;20(12):103. doi: 10.1007/s11906-018-0903-x.
7
Innate immunity and clinical hypertension.先天免疫与临床高血压。
J Hum Hypertens. 2022 Jun;36(6):503-509. doi: 10.1038/s41371-021-00627-z. Epub 2021 Oct 23.
8
Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension.白细胞介素17A参与实验性及人类高血压相关的肾脏炎症反应。
Front Pharmacol. 2019 Sep 13;10:1015. doi: 10.3389/fphar.2019.01015. eCollection 2019.
9
The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases.IL-23 独立产生 IL-17F 和 IL-17A 的范式及其在慢性炎症性疾病中的作用。
Front Immunol. 2023 Aug 4;14:1191782. doi: 10.3389/fimmu.2023.1191782. eCollection 2023.
10
The roles of interleukin (IL)-17A and IL-17F in hidradenitis suppurativa pathogenesis: evidence from human in vitro preclinical experiments and clinical samples.白细胞介素(IL)-17A和IL-17F在化脓性汗腺炎发病机制中的作用:来自人体体外临床前实验和临床样本的证据
Br J Dermatol. 2025 Mar 18;192(4):660-671. doi: 10.1093/bjd/ljae442.

引用本文的文献

1
Association between novel Immune-Inflammatory markers and hypertension patients with coronary heart disease: A Cross-Sectional study based on NHANES (2005-2016).新型免疫炎症标志物与高血压合并冠心病患者的关联:基于美国国家健康与营养检查调查(2005 - 2016)的横断面研究
BMC Cardiovasc Disord. 2025 Jul 4;25(1):467. doi: 10.1186/s12872-025-04906-2.

本文引用的文献

1
Myeloid-Specific JAK2 Contributes to Inflammation and Salt Sensitivity of Blood Pressure.髓系特异性 JAK2 有助于炎症和血压的盐敏感性。
Circ Res. 2024 Oct 11;135(9):890-909. doi: 10.1161/CIRCRESAHA.124.323595. Epub 2024 Sep 12.
2
IL-17 is associated with disease severity and targetable inflammatory processes in heart failure.白细胞介素-17与心力衰竭的疾病严重程度及可靶向的炎症过程相关。
ESC Heart Fail. 2024 Dec;11(6):3530-3538. doi: 10.1002/ehf2.14968. Epub 2024 Jul 19.
3
Changes in Inflammatory Cytokines in Responders and Non-Responders to TNFα Inhibitor and IL-17A Inhibitor: A Study Examining Psoriatic Arthritis Patients.
对TNFα抑制剂和IL-17A抑制剂有反应者与无反应者体内炎性细胞因子的变化:一项针对银屑病关节炎患者的研究
Int J Mol Sci. 2024 Mar 5;25(5):3002. doi: 10.3390/ijms25053002.
4
Association of Interleukin-17 Inhibitors With Hypertension in Patients With Autoimmune Diseases: A Systematic Review and Meta-analysis on Randomized Controlled Trials.白细胞介素-17抑制剂与自身免疫性疾病患者高血压的关联:一项关于随机对照试验的系统评价和荟萃分析
J Cardiovasc Pharmacol. 2024 Jun 1;83(6):557-564. doi: 10.1097/FJC.0000000000001547.
5
Card9/neutrophil signalling axis promotes IL-17A-mediated ankylosing spondylitis.Card9/中性粒细胞信号轴促进 IL-17A 介导的强直性脊柱炎。
Ann Rheum Dis. 2024 Jan 11;83(2):214-222. doi: 10.1136/ard-2022-223146.
6
Predictive factors of atopic-like dermatitis induced by IL-17A inhibitors in patients with psoriasis: A 2-year follow-up study.银屑病患者中白细胞介素-17A 抑制剂诱发特应性皮炎样的预测因素:一项为期 2 年的随访研究。
J Eur Acad Dermatol Venereol. 2023 Dec;37(12):2509-2516. doi: 10.1111/jdv.19394. Epub 2023 Aug 9.
7
Role of IL-17A in different stages of ischemic stroke.IL-17A 在缺血性脑卒中不同阶段中的作用。
Int Immunopharmacol. 2023 Apr;117:109926. doi: 10.1016/j.intimp.2023.109926. Epub 2023 Mar 11.
8
Progression in immunotherapy for advanced prostate cancer.晚期前列腺癌免疫治疗的进展。
Front Oncol. 2023 Feb 28;13:1126752. doi: 10.3389/fonc.2023.1126752. eCollection 2023.
9
Neurovascular Coupling in Hypertension Is Impaired by IL-17A through Oxidative Stress.高血压中的神经血管耦合通过氧化应激被 IL-17A 损害。
Int J Mol Sci. 2023 Feb 16;24(4):3959. doi: 10.3390/ijms24043959.
10
Brain Interleukin-17A contributes to neuroinflammation and cardiac dysfunction in rats with myocardial infarction.脑白细胞介素-17A 促成心肌梗死大鼠的神经炎症和心脏功能障碍。
Front Neurosci. 2022 Oct 13;16:1032434. doi: 10.3389/fnins.2022.1032434. eCollection 2022.